Company / Assets per Share
NewAmsterdam Pharma Co N.V. Assets per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$6.50
FY2025
5-year range
$4.22 / $25.23
FY2022-FY2025
Trend
-29.1%
vs FY2024
Sector context
#129 of 208
Health Care
What the data says
At $6.50, NewAmsterdam Pharma Co N.V.'s assets per share ranks #129 of 208 in the Health Care sector. Improved from $4.22 to $6.50 over the past 2 years.
Based on SEC 10-K filings.
6.50 in FY2025 with a 3-year CAGR of -36.4%.
Improved from $4.22 to $6.50 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -36.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#129 of 208 in Health CareTop 62% of 208This company $6.50 Sector average $377.57
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 29.1% year-over-year.
- Ranks #129 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.50 | -29.1% |
| FY2024 | $9.16 | +116.9% |
| FY2023 | $4.22 | -83.3% |
| FY2022 | $25.23 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026